CG Persson

897 total citations
18 papers, 694 citations indexed

About

CG Persson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, CG Persson has authored 18 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 7 papers in Immunology and Allergy. Recurrent topics in CG Persson's work include Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (9 papers) and Allergic Rhinitis and Sensitization (7 papers). CG Persson is often cited by papers focused on Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (9 papers) and Allergic Rhinitis and Sensitization (7 papers). CG Persson collaborates with scholars based in Sweden, United Kingdom and Belgium. CG Persson's co-authors include Lennart Greiff, C. Svensson, Ruben Pauwels, N. Johannesson, Morgan Andersson, I. Erjefält, M Linden, Magnus Korsgren, Jonas S. Erjefält and F. Sundler and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Alimentary Pharmacology & Therapeutics.

In The Last Decade

CG Persson

18 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CG Persson Sweden 13 518 377 252 65 54 18 694
Morgan Andersson Sweden 18 491 0.9× 241 0.6× 336 1.3× 109 1.7× 94 1.7× 39 734
Tomoko Tajiri Japan 20 661 1.3× 608 1.6× 145 0.6× 102 1.6× 80 1.5× 86 912
Betül Ayşe Sin Türkiye 12 343 0.7× 192 0.5× 254 1.0× 48 0.7× 29 0.5× 37 519
Stephen O'Hickey United Kingdom 11 295 0.6× 233 0.6× 86 0.3× 42 0.6× 56 1.0× 11 465
Claire A. Butler United Kingdom 12 444 0.9× 280 0.7× 125 0.5× 183 2.8× 89 1.6× 22 703
Chester C. Wood United States 14 334 0.6× 136 0.4× 280 1.1× 37 0.6× 45 0.8× 23 451
Lawrence M. Lichtenstein United States 13 489 0.9× 125 0.3× 454 1.8× 178 2.7× 67 1.2× 15 731
Ayaki Tanaka Japan 14 322 0.6× 171 0.5× 251 1.0× 63 1.0× 45 0.8× 30 531
Harold B. Kaiser United States 21 993 1.9× 486 1.3× 936 3.7× 62 1.0× 62 1.1× 45 1.2k
Myron Zitt United States 11 282 0.5× 155 0.4× 373 1.5× 76 1.2× 86 1.6× 22 619

Countries citing papers authored by CG Persson

Since Specialization
Citations

This map shows the geographic impact of CG Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CG Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CG Persson more than expected).

Fields of papers citing papers by CG Persson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CG Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CG Persson. The network helps show where CG Persson may publish in the future.

Co-authorship network of co-authors of CG Persson

This figure shows the co-authorship network connecting the top 25 collaborators of CG Persson. A scholar is included among the top collaborators of CG Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CG Persson. CG Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ahlström‐Emanuelsson, Cecilia, Lennart Greiff, Michael Andersson, CG Persson, & Jonas S. Erjefält. (2004). Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure. European Respiratory Journal. 24(5). 750–757. 44 indexed citations
2.
Miller‐Larsson, Anna, B. Gustafsson, CG Persson, & Ralph Brattsand. (2001). Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the rat. Alimentary Pharmacology & Therapeutics. 15(12). 2019–2025. 12 indexed citations
3.
Montnémery, Peter, C. Svensson, E Ädelroth, et al.. (2001). Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. European Respiratory Journal. 17(4). 596–603. 97 indexed citations
4.
Persson, CG, et al.. (1999). In vivo paradigms of diseased airway mucosa: selected aspects of innate immunity and eosinophils. Allergy. 54(s57). 63–72. 4 indexed citations
5.
Greiff, Lennart, Morgan Andersson, C. Svensson, et al.. (1999). Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds. European Respiratory Journal. 13(1). 41–47. 25 indexed citations
6.
Meyer, Pierre, CG Persson, Morgan Andersson, et al.. (1999). Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis. European Respiratory Journal. 13(3). 633–637. 22 indexed citations
7.
Greiff, Lennart, Morgan Andersson, C. Svensson, et al.. (1998). Effects of orally inhaled budesonide in seasonal allergic rhinitis. European Respiratory Journal. 11(6). 1268–1273. 49 indexed citations
8.
Persson, CG, Lennart Greiff, Morgan Andersson, et al.. (1998). Plasma-derived proteins in airway defence, disease and repair of epithelial injury. European Respiratory Journal. 11(4). 958–970. 76 indexed citations
9.
Greiff, Lennart, Morgan Andersson, C. Svensson, et al.. (1997). Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. European Respiratory Journal. 10(4). 841–845. 8 indexed citations
10.
Erjefält, Jonas S., Magnus Korsgren, Maria Nilsson, F. Sundler, & CG Persson. (1997). Association between inflammation and epithelial damage‐restitution processes in allergic airways in vivo. Clinical & Experimental Allergy. 27(11). 1344–1355. 45 indexed citations
11.
Svensson, C., U. Alkner, Ulf Pipkorn, & CG Persson. (1994). Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators. European Journal of Clinical Pharmacology. 46(1). 59–65. 5 indexed citations
12.
Greiff, Lennart, Per Wollmer, M. Andersson, & CG Persson. (1994). Human nasal absorption of 51Cr‐EDTA in smokers and control subjects. Clinical & Experimental Allergy. 24(11). 1036–1040. 9 indexed citations
13.
Greiff, Lennart, Morgan Andersson, C. Svensson, U. Alkner, & CG Persson. (1994). Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways. European Respiratory Journal. 7(6). 1120–1124. 19 indexed citations
14.
Erjefält, I. & CG Persson. (1992). Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clinical & Experimental Allergy. 22(9). 854–862. 32 indexed citations
16.
Greiff, Lennart, I. Erjefält, Ulf Pipkorn, & CG Persson. (1991). Effects of airway luminal concentration of albumin on histamine‐induced mucosal exudation of radio‐iodine labelled albumin. Acta Physiologica Scandinavica. 142(3). 345–349. 1 indexed citations
17.
Persson, CG. (1991). Plasma exudation in the airways: mechanisms and function. European Respiratory Journal. 4(10). 1268–1274. 39 indexed citations
18.
Pauwels, Ruben, et al.. (1985). The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. Journal of Allergy and Clinical Immunology. 76(4). 583–590. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026